Latest Tax And Regulatory News

State Street Global Advisors has announced a 70.11 cents per unit cash distribution for its flagship SPDR S&P/ASX 200 ETF, alongside franking and foreign tax credits, marking a key income event for investors as 2025 closes.

Magellan Asset Management has launched the Magellan Infrastructure Fund (Currency Hedged), an actively managed ETF trading on the ASX under ticker MICH, targeting global listed infrastructure with currency hedging and ESG integration.

ALS Limited confirms a fully franked ordinary dividend of 19.4 cents per share and announces the Dividend Reinvestment Plan price at $21.97 with no discount applied.

Forrestania Resources has lodged a replacement bidder's statement for its off-market takeover offer of Kula Gold, offering 1 Forrestania share for every 5.6 Kula shares. The Kula board unanimously recommends acceptance, highlighting strategic benefits and operational synergies.

Shriro Holdings Limited has announced a $5 million off-market share buy-back at $0.81 per share, representing nearly 8% of its issued capital and approved by shareholders. The move returns excess capital following a strategic shift and may reshape the company’s growth trajectory.

ANZ Group Holdings Limited has announced its 2025 final dividend of 83 cents per share, accompanied by a continuation of its Dividend Reinvestment and Bonus Option Plans offering a 1.5% discount. Shareholders have until mid-November to participate.

Betashares Capital Ltd has announced the final distribution amounts for October 2025 across multiple ETFs listed on the ASX AQUA market, alongside details on the Distribution Reinvestment Plan (DRP) and key dates for investors.

Betashares Capital Ltd has released estimated monthly distribution figures for 17 of its ETFs for the period ending October 2025, with payments scheduled for November. Investors are reminded these are preliminary figures subject to final confirmation.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Reece Limited has announced a $250 million off-market share buy-back priced between $11.00 and $13.00 per share, signaling confidence in its long-term strategy while maintaining financial flexibility.

Next Science has finalised the sale of nearly all its assets to OSARTIS GmbH for US$50 million, with plans to return approximately US$30 million net proceeds to shareholders following legal and tax review.

Duxton Farms Ltd has announced a scheme of arrangement to acquire all issued preference shares of Duxton Dried Fruits Pty Ltd, offering a mix of scrip and cash consideration. An independent expert has assessed the transaction as fair and reasonable, endorsing the merger as a strategic step to create a diversified agricultural investment platform.